GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

XBIO · Jun 30, 2024

Xenetic Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001683168-24-005572General Corporate
Operating cash generation100thOwn-history percentile · N=14
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-72.29% · OPTIONAL · VALID

Revenue growth10thOwn-history percentile · N=10
Evidence method

Yoy · gp.fundamentals.revenue

11.58% · CORE · VALID

Operating margin79thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.operating_margin

-184.11% · CORE · VALID

R&D intensity14thOwn-history percentile · N=14
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

128.55% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.80% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History19 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Increased
Previous
-226.96%
Current
-72.29%
Delta
154.67%
Growth Increased
Previous
-15.69%
Current
11.58%
Delta
27.27%
Profitability Increased
Previous
-248.31%
Current
-184.11%
Delta
64.20%
R And D Intensity Decreased
Previous
184.86%
Current
128.55%
Delta
-56.32%
Sbc Intensity Decreased
Previous
15.09%
Current
5.80%
Delta
-9.29%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.